{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:59:48Z","timestamp":1787979588580,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.leukres.2007.04.002","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T07:39:32Z","timestamp":1179992372000},"page":"1755-1758","source":"Crossref","is-referenced-by-count":10,"title":["Systemic mastocytosis in association with chronic lymphocytic leukemia: A rare diagnosis"],"prefix":"10.1016","volume":"31","author":[{"given":"Patricia","family":"Ault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine S.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.04.002_bib1","series-title":"World Health Organization Classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.leukres.2007.04.002_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2007.04.002_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","article-title":"Clinical and histopathological aspects of cutaneous mastocytosis","volume":"25","author":"Wolff","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2007.04.002_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2003.014860","article-title":"Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge","volume":"57","author":"Horny","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.leukres.2007.04.002_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/annonc\/mdl109","article-title":"Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154\/CD40 signaling","volume":"17","author":"Tournilhac","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2007.04.002_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3816\/CLM.2006.n.029","article-title":"CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disorders","volume":"6","author":"Santos","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.leukres.2007.04.002_bib7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJM200012143432410","article-title":"When and how to treat chronic lymphocytic leukemia","volume":"343","author":"Dighiero","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.04.002_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jcp.2005.026989","article-title":"An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL)","volume":"59","author":"Horny","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.leukres.2007.04.002_bib9","first-page":"1106","article-title":"Systemic mast cell disease associated with B-chronic lymphocytic leukemia","volume":"86","author":"Sanz","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.04.002_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.21996","article-title":"Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial","volume":"107","author":"Droogendijk","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2007.04.002_bib11","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.04.002_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.04.002_bib13","doi-asserted-by":"crossref","unstructured":"Wierda WG, O\u2019Brien S, Ferrajoli A, et al. Salvage therapy with combined cyclophosphamide (c), fludarabine (f), alemtuzumab (a), and rituximab (r) (cfar) for heavily pre-treated patients with CLL. ASH Annual Meeting Abstracts 2005;106:719.","DOI":"10.1182\/blood.V106.11.719.719"},{"key":"10.1016\/j.leukres.2007.04.002_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000048183","article-title":"Abnormal expression of CD antigens in mastocytosis","volume":"127","author":"Escribano","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.leukres.2007.04.002_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00062752-200401000-00009","article-title":"Clinical, genetic, and therapeutic insights into systemic mast cell disease","volume":"11","author":"Tefferi","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.leukres.2007.04.002_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000048184","article-title":"Surrogate markers of disease in mastocytosis","volume":"127","author":"Akin","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.leukres.2007.04.002_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000091172","article-title":"Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis","volume":"139","author":"Kushnir-Sukhov","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.leukres.2007.04.002_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0145-2126(01)00020-0","article-title":"Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders","volume":"25","author":"Schwartz","year":"2001","journal-title":"Leuk Res"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2007.04.002_bib19","first-page":"S18","article-title":"Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line","volume":"8","author":"Kanakura","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.04.002_bib20","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1200\/JCO.2005.01.9950","article-title":"Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial","volume":"23","author":"Elter","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607001282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607001282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T08:35:34Z","timestamp":1587544534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607001282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0145212607001282"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.04.002","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}